-
1
-
-
0014269485
-
-
(a) Husaka T., Yamamoto H., Shibata M., Muroi M., Kishi T., Mizuno K. J. Antibiot. 21:1967;255-263
-
(1967)
J. Antibiot.
, vol.21
, pp. 255-263
-
-
Husaka, T.1
Yamamoto, H.2
Shibata, M.3
Muroi, M.4
Kishi, T.5
Mizuno, K.6
-
2
-
-
85008049575
-
-
(b) Kishi T., Muroi M., Kusaka T., Nishikawa M., Kamiya K., Mizuno K. Chem. Pharm. Bull. 20:1972;940-946.
-
(1972)
Chem. Pharm. Bull.
, vol.20
, pp. 940-946
-
-
Kishi, T.1
Muroi, M.2
Kusaka, T.3
Nishikawa, M.4
Kamiya, K.5
Mizuno, K.6
-
8
-
-
0030007036
-
-
Deardroff D.R., Savin K.A., Justman C.J., Karanjawala Z.E., Sheppeck J.E. II, Hager D.C., Aydin N. J. Org. Chem. 61:1996;3616-3622.
-
(1996)
J. Org. Chem.
, vol.61
, pp. 3616-3622
-
-
Deardroff, D.R.1
Savin, K.A.2
Justman, C.J.3
Karanjawala, Z.E.4
Sheppeck J.E. II5
Hager, D.C.6
Aydin, N.7
-
11
-
-
0011517154
-
-
Ref. 7 reports (+)-4 by a different route
-
Ref. 7 reports (+)-4 by a different route.
-
-
-
-
12
-
-
0035829460
-
-
Song G.Y., Paul V., Choo H., Morrey J., Sidwell R.W., Schinazi R.F., Chu C.K. J. Med. Chem. 44:2001;3985-3993.
-
(2001)
J. Med. Chem.
, vol.44
, pp. 3985-3993
-
-
Song, G.Y.1
Paul, V.2
Choo, H.3
Morrey, J.4
Sidwell, R.W.5
Schinazi, R.F.6
Chu, C.K.7
-
15
-
-
0011419151
-
-
7 proved problematic in our laboratory
-
7 proved problematic in our laboratory.
-
-
-
-
17
-
-
0011461981
-
-
Use of ammonia for both ammonolysis at the purine C-6 and removal of the acetate yielded a mixture from which product could not be isolated free of acetamide. Thus, potassium carbonate in methanol was used to remove the acetyl prior to ammonolysis
-
Use of ammonia for both ammonolysis at the purine C-6 and removal of the acetate yielded a mixture from which product could not be isolated free of acetamide. Thus, potassium carbonate in methanol was used to remove the acetyl prior to ammonolysis.
-
-
-
-
19
-
-
0034919838
-
-
Santana L., Teijeira M., Terán C., Uriarte E., Vida D. Synthesis. 2001;1532-1538.
-
(2001)
Synthesis
, pp. 1532-1538
-
-
Santana, L.1
Teijeira, M.2
Terán, C.3
Uriarte, E.4
Vida, D.5
-
20
-
-
0011520499
-
-
Viruses used in the assays (highest concentration of 3 and ent-3 tested, (μg/mL) were herpes simplex virus 1 and 2 (240), human cytomegalovirus (200), varicella zoster virus (96), vesicular stomatitis virus (400), vaccinia virus (400), cowpox virus (100), coxsackie virus (80), parainfluenza-3 virus (200), reo-1 virus (80), Sindbis virus (80), Punta Toro virus (200), adenovirus-1 (200), measles (200), rhinovirus (200), influenza A and B (200), Venezuelan equine encephalitis (200), yellow fever (200), respiratory syncytial virus (200), and West Nile virus (200)
-
Viruses used in the assays (highest concentration of 3 and ent-3 tested, (μg/mL) were herpes simplex virus 1 and 2 (240), human cytomegalovirus (200), varicella zoster virus (96), vesicular stomatitis virus (400), vaccinia virus (400), cowpox virus (100), coxsackie virus (80), parainfluenza-3 virus (200), reo-1 virus (80), Sindbis virus (80), Punta Toro virus (200), adenovirus-1 (200), measles (200), rhinovirus (200), influenza A and B (200), Venezuelan equine encephalitis (200), yellow fever (200), respiratory syncytial virus (200), and West Nile virus (200).
-
-
-
-
21
-
-
0011519982
-
-
3]
-
3].
-
-
-
|